Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD | ACAD Message Board Posts

ACADIA Pharmaceuticals Inc.

  ACAD website
  • Here We Go Again: Apparently, it's just one of those years. We here in the Greater New Orleans Area now find ourselves "in the cone" for the 7th time this year. And while we more or less dodged bullets the first 6 times, it looks like this time Zeta is going to hit close enough to do damage. We can only hope it stays a relatively minor Cat 1 & weakens upon approach. But preparations are once again in order for those of us living along the central Gulf Coast. Members with family or other interests in the affected area are welcome to post on the new Hurricane Zeta Self-Help board we just set up. Good luck & stay safe! 

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  17081 of 17156  at  9/23/2020 9:50:47 AM  by

BelieverTim


 In response to msg 17080 by  Biotech_Jim
view thread

Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD

I own some KRTX shares. ACADís pimavanserin is going to always have the advantage (if the efficacy is adequate for patient) based on minimal side effects. Tomahawk cruise missiles can very precisely deliver a 1,000 lb conventional war head at a cost of $832,000. A 2,000 lb unguided conventional bomb seems like a bargain at $16,000...until you consider collateral damage (side effects). Just like the military has multiple tools in the bag, there will be a need for multiple antipsychotics. ACAD will not be the only game in town, but it is the Tomahawk cruise missile in itsí class. If you donít own a few shares, you should probably plan to add some at the next market/sector downturn.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 300
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
17082 Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD Biotech_Jim 4 9/23/2020 10:07:53 AM






Financial Market Data provided by
.
Loading...